Patents by Inventor John Maslowski

John Maslowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of vocal cords with autologous dermal fibroblast formulation
    Patent number: 8765121
    Abstract: Dosage units consist of an autologous cell therapy product composed of fibroblasts grown for each individual to be treated for augmentation or regeneration of vocal cords. The suspension of autologous fibroblasts, grown from a biopsy of each individual's own buccal mucosa or skin using current good manufacturing practices (CGMP) and standard tissue culture procedures, is supplied in vials containing cryopreserved fibroblasts or precursors thereof, having a purity of at least 98% fibroblasts and a viability of at least 85%, for administration of from one to six mL, preferably two mL administered three times approximately three to six weeks apart, of cells at a concentration of from 1.0-2.0×107 cells/mL.
    Type: Grant
    Filed: October 14, 2011
    Date of Patent: July 1, 2014
    Assignee: Fibrocell Technologies, Inc.
    Inventor: John Maslowski
  • Methods for culturing minimally-passaged fibroblasts and uses thereof
    Patent number: 8728819
    Abstract: The present invention relates to novel methods of growing at least 100 million minimally-passaged fibroblasts from a small biopsy specimen. The invention includes methods wherein a small biopsy specimen is seeded directly into a large tissue culture flask, and passaged no more than three times.
    Type: Grant
    Filed: August 29, 2007
    Date of Patent: May 20, 2014
    Assignee: Fibrocell Technologies, Inc.
    Inventors: John Maslowski, Myrna F. Thomas, Marie A. Lindner
  • Treatment of Vocal Cords with Autologous Dermal Fibroblast Formulation
    Publication number: 20130224160
    Abstract: Dosage units consist of an autologous cell therapy product composed of fibroblasts grown for each individual to be treated for augmentation or regeneration of vocal cords. The suspension of autologous fibroblasts, grown from a biopsy of each individual's own buccal mucosa or skin using current good manufacturing practices (CGMP) and standard tissue culture procedures, is supplied in vials containing cryopreserved fibroblasts or precursors thereof, having a purity of at least 98% fibroblasts and a viability of at least 85%, for administration of from one to six mL, preferably two mL administered three times approximately three to six weeks apart, of cells at a concentration of from 1.0-2.0×107 cells/mL.
    Type: Application
    Filed: October 14, 2011
    Publication date: August 29, 2013
    Applicant: FIBROCELL TECHNOLOGIES, INC.
    Inventor: John Maslowski
  • METHODS FOR CULTURING DERMAL CELLS FOR TREATMENT OF SKIN INJURIES SUCH AS BURNS
    Publication number: 20100303770
    Abstract: The present invention relates to novel methods of growing or otherwise producing unpassaged or minimally-passaged dermal cells from a small biopsy specimen for treating skin injuries significantly larger than the biopsy.
    Type: Application
    Filed: December 27, 2007
    Publication date: December 2, 2010
    Inventors: John Maslowski, Myrna F. Thomas, Marie A. Lindner
  • Methods for Culturing Minimally-Passaged Fibroblasts and Uses Thereof
    Publication number: 20100297088
    Abstract: The present invention relates to novel methods of growing at least 100 million minimally-passaged fibroblasts from a small biopsy specimen. The invention includes methods wherein a small biopsy specimen is seeded directly into a large tissue culture flask, and passaged no more than three times.
    Type: Application
    Filed: August 29, 2007
    Publication date: November 25, 2010
    Applicant: Isolagen Technologies, Inc.
    Inventors: John Maslowski, Myrna F. Thomas, Marie A. Lindner